Umbilical cord stem cells implanted into Covid patients improve survival chances, study suggests | The Independent
An experimental treatment involving stem cells from umbilical cords could significantly reduce deaths and quicken recovery time for patients suffering the most severe form of Covid-19, a study suggests.
US researchers reported a 91 per cent survival rate in seriously ill patients given the stem cell infusion, compared to 42 per cent in a second group who did not receive the treatment.
NCIM: Its founding & distinctives | LAB PRIMED STEM CELLS. DONOR IMMUNE CELLS FOR CANCER. STEM CELL HOMING BEACON FACTOR. +1-562-916-3410. (ncimexico.com)
The adult stem cells Nova Cells uses include umbilical cord (Mesenchymals and others), Wharton’s Jelly, placenta-derived, and a patient’s own bone marrow.
In a Science Digest article published on 11-24-2020 and titled “World’s first: Drug guides stem cells to desired location, improving their ability to heal” the SD staff writer states that the “..Scientists at Sanford Burnham Presby Medical Discovery Institute have created a drug that can lure stem cells to damaged tissue and improve treatment efficacy — a scientific first and major advance for the field of regenerative medicine.”
Maybe this is a “scientific first” for Sanford Burnham Presby Medical Discovery Institute but not for Nova Cells Institute of Mexico (NCIM) which introduced a stem cell homing compound it created back in 2015! Dubbed the “Beacon Factor” you can read about it here and in a July 2015 blog entry here.
NCIM introduced its stem cell homing “Beacon Factor” in 2015. Sanford Burnham Presby Medical Discovery Institute announced their stem cell homing creation this year, 2020. five years after NCIM. Five years. Better late than never comes to mind. This and “such hubris”….. to call SBPDI’s latecomer a “scientific first” , that is.
Nova Cells Institute of Mexico: the little guys who have made progress on a shoestring budget, egged on by an overwhelming desire to revolutionize healthcare…..one (patient) turnaround at a time.
If you need help with questions or concerns about stem cell therapies, NCIM’s proprietary Beacon Factor, patient responses to treatment, or just about anything else then grab your phone or keyboard and contact NCIM.
Phone NCIM at 1-562-916-3410.
You can also shoot NCIM a message using this online form: